Evidence map›Paper›PMID 39582319›Full record

ArticleFuture oncology (London, England)2025

Current practices for the management of advanced high-grade epithelial ovarian cancer in the UK: OC-NOW survey (2023).

Christina Fotopoulou, Rebecca Bowen, Ranjit Manchanda, Agnieszka Michael, Stephen McCormack, Allan Ullmann, Anthony Wesselbaum, Bethany Levick, Rowan Miller

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christina FotopoulouFaculty of Medicine, Department of Surgery & Cancer, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.ORCID 0000-0001-6375-9645
Rebecca BowenRoyal United Hospitals Bath NHS Foundation Trust, Combe Park, Bath, BA1 3NG, UK.
Ranjit ManchandaBarts & the Royal London Hospital, Whitechapel Road, London, E1 1BB, UK.ORCID 0000-0003-3381-5057
Agnieszka MichaelRoyal Surrey NHS Foundation Trust, 6 High Street, Cranleigh, GU6 8AE, UK.ORCID 0000-0002-7262-6227
Stephen McCormackGSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.ORCID 0000-0003-3264-7733
Allan UllmannGSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Anthony WesselbaumGSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Bethany LevickEvidence & Access, OPEN Health, 20 Old Bailey, London, EC4M 7AN, UK.ORCID 0000-0002-6371-8744
Rowan MillerSt. Bartholomew's Hospital, W Smithfield, London, EC1A 7BE, UK.

Funding

GlaxoSmithKline
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Ovarian EpithelialOvarian NeoplasmsPractice Patterns, Physicians'BRCA1 ProteinBRCA2 ProteinCross-Sectional StudiesCytoreduction Surgical ProceduresDisease ManagementFemaleHumansMutationNeoplasm GradingNeoplasm Recurrence, LocalPoly(ADP-ribose) Polymerase InhibitorsSurveys and QuestionnairesUnited KingdomBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanPoly(ADP-ribose) Polymerase InhibitorsbiomarkerBRCAmanagementOC-NOWovarian cancerPARP inhibitors

Identifiers

PMID39582319
PMCPMC11975060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.